Cargando…
Novel Biphasic Role of Resolvin D1 on Expression of Cyclooxygenase-2 in Lipopolysaccharide-Stimulated Lung Fibroblasts Is Partly through PI3K/AKT and ERK2 Pathways
Fibroblasts, far frombeing merely bystander cells, are known to play a specific role in inflammation resolution after an acute injury. As the endogenous “braking signal,” resolvins possess potent anti-inflammatory and proresolution actions. We demonstrated that the expression of COX-2 protein was si...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794569/ https://www.ncbi.nlm.nih.gov/pubmed/24174713 http://dx.doi.org/10.1155/2013/964012 |
_version_ | 1782287219927547904 |
---|---|
author | Wu, Derong Zheng, Shengxing Li, Wenjuan Yang, Li Liu, Yongjian Zheng, Xia Yang, Yi Yang, Liangmin Wang, Qian Smith, Fang Gao Jin, Shengwei |
author_facet | Wu, Derong Zheng, Shengxing Li, Wenjuan Yang, Li Liu, Yongjian Zheng, Xia Yang, Yi Yang, Liangmin Wang, Qian Smith, Fang Gao Jin, Shengwei |
author_sort | Wu, Derong |
collection | PubMed |
description | Fibroblasts, far frombeing merely bystander cells, are known to play a specific role in inflammation resolution after an acute injury. As the endogenous “braking signal,” resolvins possess potent anti-inflammatory and proresolution actions. We demonstrated that the expression of COX-2 protein was significantly peaked initially at 6 hours but then also at 48 hours after LPS stimulation in lung fibroblasts. PGE(2) levels also peaked at 6 hours, and PGD(2) levels were increased and peaked at 48 hours. However, no significant change in the protein expression of COX-1 was observed after treatment with LPS in lung fibroblasts. Exogenous resolvin D1 inhibited the first peak of COX-2 expression as well as the production of PGE(2) induced by LPS. In contrast, exogenous resolvin D1 increased the second peak of COX-2 expression as well as the production of PGD(2) induced by LPS. In addition, resolvin D1 inhibited COX-2 expression at 6 hours, which was partly through PI3K/AKT and ERK2 signalling pathways. |
format | Online Article Text |
id | pubmed-3794569 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-37945692013-10-30 Novel Biphasic Role of Resolvin D1 on Expression of Cyclooxygenase-2 in Lipopolysaccharide-Stimulated Lung Fibroblasts Is Partly through PI3K/AKT and ERK2 Pathways Wu, Derong Zheng, Shengxing Li, Wenjuan Yang, Li Liu, Yongjian Zheng, Xia Yang, Yi Yang, Liangmin Wang, Qian Smith, Fang Gao Jin, Shengwei Mediators Inflamm Research Article Fibroblasts, far frombeing merely bystander cells, are known to play a specific role in inflammation resolution after an acute injury. As the endogenous “braking signal,” resolvins possess potent anti-inflammatory and proresolution actions. We demonstrated that the expression of COX-2 protein was significantly peaked initially at 6 hours but then also at 48 hours after LPS stimulation in lung fibroblasts. PGE(2) levels also peaked at 6 hours, and PGD(2) levels were increased and peaked at 48 hours. However, no significant change in the protein expression of COX-1 was observed after treatment with LPS in lung fibroblasts. Exogenous resolvin D1 inhibited the first peak of COX-2 expression as well as the production of PGE(2) induced by LPS. In contrast, exogenous resolvin D1 increased the second peak of COX-2 expression as well as the production of PGD(2) induced by LPS. In addition, resolvin D1 inhibited COX-2 expression at 6 hours, which was partly through PI3K/AKT and ERK2 signalling pathways. Hindawi Publishing Corporation 2013 2013-09-23 /pmc/articles/PMC3794569/ /pubmed/24174713 http://dx.doi.org/10.1155/2013/964012 Text en Copyright © 2013 Derong Wu et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Wu, Derong Zheng, Shengxing Li, Wenjuan Yang, Li Liu, Yongjian Zheng, Xia Yang, Yi Yang, Liangmin Wang, Qian Smith, Fang Gao Jin, Shengwei Novel Biphasic Role of Resolvin D1 on Expression of Cyclooxygenase-2 in Lipopolysaccharide-Stimulated Lung Fibroblasts Is Partly through PI3K/AKT and ERK2 Pathways |
title | Novel Biphasic Role of Resolvin D1 on Expression of Cyclooxygenase-2 in Lipopolysaccharide-Stimulated Lung Fibroblasts Is Partly through PI3K/AKT and ERK2 Pathways |
title_full | Novel Biphasic Role of Resolvin D1 on Expression of Cyclooxygenase-2 in Lipopolysaccharide-Stimulated Lung Fibroblasts Is Partly through PI3K/AKT and ERK2 Pathways |
title_fullStr | Novel Biphasic Role of Resolvin D1 on Expression of Cyclooxygenase-2 in Lipopolysaccharide-Stimulated Lung Fibroblasts Is Partly through PI3K/AKT and ERK2 Pathways |
title_full_unstemmed | Novel Biphasic Role of Resolvin D1 on Expression of Cyclooxygenase-2 in Lipopolysaccharide-Stimulated Lung Fibroblasts Is Partly through PI3K/AKT and ERK2 Pathways |
title_short | Novel Biphasic Role of Resolvin D1 on Expression of Cyclooxygenase-2 in Lipopolysaccharide-Stimulated Lung Fibroblasts Is Partly through PI3K/AKT and ERK2 Pathways |
title_sort | novel biphasic role of resolvin d1 on expression of cyclooxygenase-2 in lipopolysaccharide-stimulated lung fibroblasts is partly through pi3k/akt and erk2 pathways |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794569/ https://www.ncbi.nlm.nih.gov/pubmed/24174713 http://dx.doi.org/10.1155/2013/964012 |
work_keys_str_mv | AT wuderong novelbiphasicroleofresolvind1onexpressionofcyclooxygenase2inlipopolysaccharidestimulatedlungfibroblastsispartlythroughpi3kaktanderk2pathways AT zhengshengxing novelbiphasicroleofresolvind1onexpressionofcyclooxygenase2inlipopolysaccharidestimulatedlungfibroblastsispartlythroughpi3kaktanderk2pathways AT liwenjuan novelbiphasicroleofresolvind1onexpressionofcyclooxygenase2inlipopolysaccharidestimulatedlungfibroblastsispartlythroughpi3kaktanderk2pathways AT yangli novelbiphasicroleofresolvind1onexpressionofcyclooxygenase2inlipopolysaccharidestimulatedlungfibroblastsispartlythroughpi3kaktanderk2pathways AT liuyongjian novelbiphasicroleofresolvind1onexpressionofcyclooxygenase2inlipopolysaccharidestimulatedlungfibroblastsispartlythroughpi3kaktanderk2pathways AT zhengxia novelbiphasicroleofresolvind1onexpressionofcyclooxygenase2inlipopolysaccharidestimulatedlungfibroblastsispartlythroughpi3kaktanderk2pathways AT yangyi novelbiphasicroleofresolvind1onexpressionofcyclooxygenase2inlipopolysaccharidestimulatedlungfibroblastsispartlythroughpi3kaktanderk2pathways AT yangliangmin novelbiphasicroleofresolvind1onexpressionofcyclooxygenase2inlipopolysaccharidestimulatedlungfibroblastsispartlythroughpi3kaktanderk2pathways AT wangqian novelbiphasicroleofresolvind1onexpressionofcyclooxygenase2inlipopolysaccharidestimulatedlungfibroblastsispartlythroughpi3kaktanderk2pathways AT smithfanggao novelbiphasicroleofresolvind1onexpressionofcyclooxygenase2inlipopolysaccharidestimulatedlungfibroblastsispartlythroughpi3kaktanderk2pathways AT jinshengwei novelbiphasicroleofresolvind1onexpressionofcyclooxygenase2inlipopolysaccharidestimulatedlungfibroblastsispartlythroughpi3kaktanderk2pathways |